Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.97 USD | +0.25% | -0.25% | -24.67% |
Mar. 13 | Craig-Hallum Adjusts Price Target on Bioventus to $9 From $6, Maintains Buy Rating | MT |
Mar. 12 | Transcript : Bioventus Inc., Q4 2023 Earnings Call, Mar 12, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.67% | 253M | |
+73.37% | 12.39B | |
-17.09% | 8.08B | |
+16.88% | 7.25B | |
+3.57% | 5.86B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-17.74% | 4.19B | |
-35.26% | 2.44B | |
+3.09% | 2.07B |
- Stock Market
- Equities
- BVS Stock
- News Bioventus Inc.
- Transcript : Bioventus Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-14-2022 11